Cartesian Therapeutics CVR
13F holders, Q3 2024 (September 30)3holders
0new positions
1sold out
$0.08avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 1 sold out. The largest holders were Erste Asset Management GmbH ($207K), Sterling Capital Management LLC ($6K) and Ironwood Investment Management LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 787 shares bought and 237 shares sold, net +550 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Erste Asset Management GmbH | 0.00% | No change | 2,527,000 | $207K |
| Sterling Capital Management LLC | 0.00% | — | 8,268 | $6K |
| Ironwood Investment Management LLC | 0.00% | Add +0.5% | 173,995 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.